Journal
NATURE CHEMICAL BIOLOGY
Volume 5, Issue 9, Pages 655-663Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nchembio.193
Keywords
-
Categories
Funding
- US National Institute of Neurological Disorders and Stroke (NINDS) [R21]
- National Institute on Aging
- American Parkinson Disease Association
- Michael J. Fox Foundation
- US National Institute of Environmental Health Sciences
Ask authors/readers for more resources
Phage display has demonstrated the utility of cyclic peptides as general protein ligands but cannot access proteins inside eukaryotic cells. Expanding a new chemical genetics tool, we describe the first expressed library of head-to-tail cyclic peptides in yeast (Saccharomyces cerevisiae). We applied the library to selections in a yeast model of alpha-synuclein toxicity that recapitulates much of the cellular pathology of Parkinson's disease. From a pool of 5 million transformants, we isolated two related cyclic peptide constructs that specifically reduced the toxicity of human alpha-synuclein. These expressed cyclic peptide constructs also prevented dopaminergic neuron loss in an established Caenorhabditis elegans Parkinson's model. This work highlights the speed and efficiency of using libraries of expressed cyclic peptides for forward chemical genetics in cellular models of human disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available